Innovative Research, Inc. Acquires Molecular Innovations, Inc.

Posted by Adam Awdish on

Novi, MI, October 1, 2021 - Innovative Research, Inc. has finalized its agreement to acquire Molecular Innovations, Inc.  “These two companies have been strategic partners for the past twenty years, it only makes sense they merge and improve future collaboration and operations,” says Carl Rosenblum, Director of Customer Support at Innovative Research.  “As we went through this process it became clearer what we were gaining as a total organization by joining Innovative Research,” said Duane Day, President and Owner of Molecular Innovations, Inc.

This combination of resources will allow Innovative Research to leverage the thirty years of high-quality production and expertise in coagulation and thrombolysis while identifying new areas of product development and investment to meet customer need. Headquarters will be maintained in Novi, MI and Innovative Research will continue to provide reliable reagents to clients both domestic and International.

If you have an unfulfilled Molecular Innovations Sales Order, you will be notified with updated information on October 4, 2021. Should your original PO need revised for proper fulfillment, your assistance in doing so is appreciated.  Please direct any inquiries to Carl Rosenblum, 248-896-0145, ext. 102.

Share this post

Related Posts

Innovative Research Partnership with BioscienceLA
Innovative Research has partnered with BioscienceLA, a nonprofit organization located i...
Read the Article
Donna Schelby Named as CEO of Innovative Research, Inc.
We are pleased to announce that Donna Schelby has been named as CEO of Innovative Resea...
Read the Article
And the winner is...
It is now time to announce that the $10,000 Grant for Post-Doctorate Research in the Li...
Read the Article

← Older Post Newer Post →